Mar 31, 2018

ANI Pharmaceuticals Q1 2018 Earnings Report

Total Revenue
$46.5M
Previous year: $36.6M
+26.9%
EPS
$1.32
Previous year: $0.74
+78.4%
Gross Profit
$25.8M
Previous year: $20.2M
+27.4%
Cash and Equivalents
$52M
Previous year: $10.8M
+380.0%
Free Cash Flow
$20.7M
Previous year: $4.39M
+370.3%
Total Assets
$418M
Previous year: $357M
+17.0%

ANI Pharmaceuticals

ANI Pharmaceuticals